TG Therapeutics, Inc.TGTXNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year gross profit growth rate
| Period | Value |
|---|---|
| Q3 2025 | 9.28% |
| Q2 2025 | 16.04% |
| Q1 2025 | 13.50% |
| Q4 2024 | 24.48% |
| Q3 2024 | 14.39% |
| Q2 2024 | 12.44% |
| Q1 2024 | 60.86% |
| Q4 2023 | -77.80% |
| Q3 2023 | 1045.99% |
| Q2 2023 | 103.90% |
| Q1 2023 | 8920.78% |
| Q4 2022 | -16.30% |
| Q3 2022 | -83.89% |
| Q2 2022 | -67.90% |
| Q1 2022 | -15.73% |
| Q4 2021 | 21.46% |
| Q3 2021 | 24.41% |
| Q2 2021 | 113.61% |
| Q1 2021 | 1061.76% |
| Q4 2020 | -278.95% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 100.02% |
| Q4 2019 | -444881.58% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | -0.25% |
| Q4 2017 | -0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 100.00% |
| Q4 2016 | -207289815.21% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | -0.00% |